Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute
Recalled by Domino Foods Inc
Food recall
Domino Foods Inc
Class III — least serious
Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Domino Foods Inc has recalled Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on February 18, 2026 and was initiated on January 13, 2026. It is classified as a Class III recall, which means using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute, with approximately 2,023 cases affected. The company behind the recall is Domino Foods Inc, based in West Palm Beach, FL. The FDA describes the product as: “Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute, Net Wt 0.035 oz. (1g), Manufactured by Domino Foods, Inc., West Palm Beach, FL 33041”
Why was Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute recalled?
According to the FDA, the stated reason for the recall is: “Undeclared Aspartame.” In plain terms, this recall relates to an undeclared ingredient or allergen.
An undeclared ingredient means a food contains something — often a major allergen such as milk, eggs, soy, wheat, peanuts, or tree nuts — that is not listed on the label. For most people this is not dangerous, but for someone with a food allergy or sensitivity it can trigger a serious reaction. Accurate labeling is required so that people can avoid ingredients they need to stay away from.
What should you do?
If you think you may have bought Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute, compare it against the product description and identifying codes (Lot # 35414, 35416, 35421, 35435) before using it.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Domino Foods Inc or your local health authority.
About this recall
This recall was distributed in FL. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Terminated
- Date reported
- February 18, 2026
- Recall started
- January 13, 2026
- Distributed in
- FL
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute recalled?+
According to the FDA: Undeclared Aspartame
How serious is this recall?+
Class III — least serious. Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
What should I do if I have Sodexo Stars Saccharin (Pink) Packets, Sugar Substitute?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: H-0497-2026. Information last synced from the FDA on July 6, 2026.